The Institute is hosting, or participating in, the following centres:
Oslo Center for Biostatistics and Epidemiology is an interinstitutional center comprising the Department of Biostatistics at the University of Oslo (UiO) and the Department of Biostatistics, Epidemiology and Health economy at the Oslo University Hospital (OUS).
Staff at the center perform research, are invovled in teaching on all levels at the Faculty of Medicine, UiO, and offer statistical consulting for students and researchers at UiO, OUS and HSØ.
This specialized centre for in vivo optical imaging is constructed and equipped with instruments donated to CMBN by the Letten Foundation. The centre is led by professor Erlend A. Nagelhus and focuses on synapse dynamics and neuro-glio-vascular interactions in brain disease.
The Letten Centre is linked to CMBN at IMB and operates under the Nordic EMBL-partnership for molecular medicine.
The Norwegian Center for Stem Cell Research is administered by the Oslo University Hospital (OUS), but localised at IMB under an agreement between the university and the hospital: the aim is to increase translational bridges from basic science to clinical treatments.
The center is led by IMB professor Joel Glover, and includes 11 research and clinical groups at UiO and OUS. Six of the research groups (Glover, Collas, Moskaug, Brinchmann, Klungland and Sullivan) are at or affiliated with IMB, and a key element in the implementation of translational efforts is the localisation of the laboratory of OUS researcher Jan E. Brinchmann at IMBs Department of Biochemistry.
The Center also operates a National Core Facility for the production, maintenance and characterization of human pluripotent stem cells, located at IMB.
The Norwegian Center for Stem Cell Research was established as an initiative from the Ministry of Health with a mandate to coordinate basic and translational stem cell research in Norway, develop a national platform for human pluripotent stem cell research, provide training in stem cell biology and techniques, and fuel public awareness on stem cell-related issues.
The Cancer Stem Cell Innovation Center is a Norwegian Centre for Research-based Innovation with one partner from IMB. The aim of SFI-CAST is to develop new therapeutic approaches based on stem cell parameters in human cancer.
Statistics for Innovation is a Norwegian Centre for Research-based Innovation with representation from the IMB Department of Biostatistics. The centre develops core statistical methodologies, strategically necessary to achieve innovation goals in four key sectors: petroleum, finance, marine and health.